retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Transforming obesity: The advancement of

No need to step through the lower doses again.It's a straightforward switch and for many, probably a welcome one.The MHRA's approval marks the first time a GLP-1 tablet of this kind has been cleared for use in the UK, and it signals a broader shift in how weight management treatment might look in the years ahead

They stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning they promote insulin release only when blood glucose levels are elevated

The weekly dosing convenience is one reason GLP-1 medications have gained such widespread adoption, with many patients preferring one injection per week to the daily injections that insulin protocols require

..I wrote one-third of the LessWrong posts I've ever written in the last month [3]

Over the counter antihistamines like diphenhydramine (Benadryl) or cetirizine (Zyrtec) can reduce itching and minor allergic type reactions at injection sites

Injectables can over-plump or distort facial contours if not done carefully, and surgical options are invasive and irreversible